Annarita Egidi, new general manager of Takeda Italy
From 1 April Annarita Egidi will be General Manager of Takeda Italy, succeeding Rita Cataldo after 5 years, called to take on the position of General Manager of Takeda France.
Annarita Egidi he comments on this important turning point: “Start now for me and for Takeda Italia a new phase. The company has closed an extraordinary 2020: in fact, in the middle of the pandemic wave, the integration with Shire and, although working almost entirely remotely, the Organization guaranteed the performance of all activities, keeping constant attention to patients. The pandemic today confronts us with a constantly changing context. The new needs of patients, the pressure on the healthcare system, the crucial role of Digital Health clearly show us the need for a change. My mandate will therefore be based on the enhancement of flexibility and the ability to listen to all our interlocutors: only in this way Takeda it will be able to make available to patients, doctors and the country system all the value it is capable of, both in terms of innovative treatments and “beyond the pill” solutions. New circumstances require more agile responses and solutions and, by focusing on the enhancement of our people and the continuous development of new skills, we will be able to grow together with Italy. And make a difference in people’s lives: this commitment will be my guide, this is the Vision of Takeda Italia”.
“Annarita’s appointment as General Manager Italy, with her background in the pharmaceutical sector and success in managing our Italian Oncology Division over the past three years, reinforces Italy’s importance as a key market for Takeda in Europe; it likewise reflects our ongoing commitment to promoting diversity within our management teams, “he specifies Giles Platford, President of Europe and Canada.
Degree in Pharmaceutical Chemistry and Technology, Master in Economics and experience in various roles of the company organization, from medical scientific information, to brand management, to drug pricing and reimbursement, gained in Recordati, GlaxoSmithKline and Pfizer, Annarita Egidi is in Takeda Italy since 2013, where until 2018 he held the role of Market Access Director.
In this position he led projects aimed at facilitating access to innovative drugs for the treatment of inflammatory bowel diseases and in the areas of oncology, onco-hematology and diabetes. In recent years Egidi has contributed to promoting Lean Management projects in Healthcare, for the optimization of processes and for the improvement of patients’ quality of life, in partnership with local and regional institutions. Since 2018, as Country Head of the Oncology Division, Egidi has led Takeda to a great growth in the Oncology area, launching a dedicated division, characterized by independent management, which guaranteed agility and speed of action at the service of cancer patients. His work has also enhanced Takeda’s presence in lung cancer, confirming the company’s great commitment to precision medicine. In 2020, under the guidance of Egidi, the public awareness initiative “The sense of words – Another communication is possible in oncology” is carried out, with the aim of supporting patients, caregivers and clinicians through the construction of a language common that can facilitate full mutual understanding.